Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7.23M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
57.3M
-
Shares change
-
-126K
-
Total reported value, excl. options
-
$403M
-
Value change
-
-$11.1M
-
Put/Call ratio
-
0
-
Number of buys
-
64
-
Number of sells
-
-59
-
Price
-
$7.04
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2022
147 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q4 2022.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.3M shares
.
Largest 10 shareholders include Avidity Partners Management LP (6.78M shares), ORBIMED ADVISORS LLC (4.58M shares), STATE STREET CORP (4.25M shares), BlackRock Inc. (4.23M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.5M shares), Bellevue Group AG (3.03M shares), VANGUARD GROUP INC (3.03M shares), MILLENNIUM MANAGEMENT LLC (2.9M shares), CHI Advisors LLC (1.89M shares), and Prosight Management, LP (1.75M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.